Invitation letter for COVID-19 vaccination for people aged 85-89 years arriving today Today, the first 50,000 people in the age group from 85-89 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
COVID-19 vaccinations for first residents of nursing homes and small-scale residential facilities Today, the first COVID-19 vaccines will be administered to residents of nursing homes and care facilities for people with intellectual disabilities in the Netherlands.
First COVID-19 vaccination in the Netherlands given at GGD vaccination site in Veghel Care workers in nursing homes and small-scale residential facilities received the first COVID-19 vaccinations in the Netherlands this morning at the GGD vaccination location ‘Hart voor Brabant’ in
Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.
First COVID-19 vaccination in the Netherlands on 8 January 2021 If the European Medicines Agency (EMA) approves BioNTech/Pfizer’s COVID-19 vaccine next week, the first people in the Netherlands will receive the COVID-19 vaccine on Friday 8 January 2021.
Possible start of COVID-19 vaccination in early January If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.
Discussion regarding health-based guidance value of PFOA The European Food Safety Authority (EFSA) has published a provisional health-based guidance value for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Blood spot test extended as of 1 January 2017 to include two more disorders As of 1 January 2017, the disorders alpha and beta thalassaemia will be added to the neonatal blood spot (‘heel prick’) screening programme.
Guus Velders in Nature's "Ten people that mattered this year" Researcher Dr Guus Velders of RIVM has made the Nature top-10 list of 2016. This means that, according to Nature, he was one of the 10 most influential scientists in 2016.